Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese
Authors:
Open Access
- 6 November 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (23) , 21219-21228
Abstract
Backgroud: Multiple studies have identified pathogenic germline variants in cancer susceptibility genes (CSGs) in Chinese lung cancer patients; however, accurate assessment of these variants' contributions to cancer predisposition is always hampered by the absence of data on the prevalence of these variants in the general population. It is necessary to conduct a large‐scale case–control study to identify CSGs that significantly increase the risk of lung cancer.Materials and methods: We performed targeted sequencing of a CSGs panel in 1117 lung cancer patients and 16,327 controls from the general Chinese population.Results: In comparison to controls, lung cancer patients had a considerably higher prevalence of pathogenic and likely pathogenic (P/LP) variations. Among lung cancer patients, 72% of P/LP variants carriers did not have a family cancer history, who would be ignored if germline testing was only provided for patients meeting family history‐based criteria. Furthermore, compared to individuals with late‐onset lung cancer, patients with early‐onset lung cancer had a considerably higher prevalence of P/LP variations. With odds ratios (ORs) ranging from 4‐fold (BRCA1: OR, 4.193; 95%CI, 1.382–10.768) to 29‐fold (TP53: OR, 29.281; 95%CI, 1.523–1705.506), P/LP variants in the BRCA1 and TP53 genes were discovered to be strongly related to increased lung cancer risk. Additionally, with ORs ranging from 7.322‐fold to infinity, we discovered 23 variations previously categorized as non‐P/LP variants were highly enriched in lung cancer patients.Conclusion: Our findings indicated that P/LP variants in BRCA1 and TP53 conferred increased risk of lung cancer in Chinese.Keywords
This publication has 35 references indexed in Scilit:
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- A Recurrent Mutation in PARK2 Is Associated with Familial Lung CancerThe American Journal of Human Genetics, 2015
- Germline EGFR T790M Mutation Found in Multiple Members of a Familial CohortJournal of Thoracic Oncology, 2014
- Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort studyBMJ, 2012
- Unclassified variants in BRCA genes: guidelines for interpretationAnnals of Oncology, 2011
- Genetic polymorphisms ofMPO,GSTT1,GSTM1,GSTP1,EPHX1andNQO1as risk factors of early‐onset lung cancerInternational Journal of Cancer, 2010
- An epidemiologic study of early onset lung cancerLung Cancer, 2006
- Genetic testing for hereditary cancers: The impact of gender on interest, uptake and ethical considerationsCritical Reviews in Oncology/Hematology, 2006
- Inherited predisposition to early onset lung cancer according to histological typeInternational Journal of Cancer, 2004
- The Attribution of Lung Cancers to Asbestos ExposureAmerican Journal of Clinical Pathology, 2002